VWM
RDHL

Vermillion Wealth Management’s Redhill Biopharma RDHL Stock Holding History

Vermillion Wealth Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
2
– – ﹤0.01% 1516
2026
Q1 		$1 Hold
2
– – ﹤0.01% 1560
2025
Q4 		$2 Hold
2
– – ﹤0.01% 619
2025
Q3 		$4 Hold
2
– – ﹤0.01% 1526
2025
Q2 		$4 Hold
2
– – ﹤0.01% 529
2025
Q1 		$5 Hold
2
– – ﹤0.01% 1314
2024
Q4 		$12 Buy
+2
New +$15 ﹤0.01% 545

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Vermillion Wealth Management's RDHL Position: Q2 2026 in Review

Vermillion Wealth Management held its Redhill Biopharma (RDHL) position steady in Q2 2026 at 2 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1516.

Vermillion Wealth Management first reported a position in RDHL in Q4 2024 and has held it in 7 quarters since. The position peaked at $12 in Q4 2024. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • Vermillion Wealth Management held 2 shares of Redhill Biopharma worth $2 as of Q2 2026.
  • Vermillion Wealth Management left its Redhill Biopharma share count unchanged in Q2 2026.
  • Redhill Biopharma made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #1516 holding.
  • Vermillion Wealth Management first reported a position in Redhill Biopharma in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Redhill Biopharma position peaked at $12 in Q4 2024.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.